Percutaneous Interventional Cardiovascular Medicine, 4 Vols. the Pcr-Eapci Textbook + Online Version

Description

The reference for interventional practitioners, comprising of four volumes dedicated to diagnosis, coronary interventions, structural heart disease, peripheral interventions and perspectives. Both clinically and practically oriented, the Textbook covers everything today's interventionalist needs to know. The 4-volume, hardcover set is presented in a slipcase with more than 2,300 pages.

Full Details

• The PCR-EAPCI Percutaneous Interventional Cardiovascular Medicine Textbook is the first of its kind, all-inclusive reference whose scope and content is patient-centred and promotes good, evidence-based clinical practices.
• It is poised to become the reference for interventional practioners. There are four volumes dedicated to diagnosis, coronary interventions, structural heart disease, peripheral interventions and perspectives.

Table of contents

VOLUME I

From the editors: Introducing the digital edition of The PCR-EAPCI Percutaneous Interventional Cardiovascular Medicine Textbook
Foreword: A European touch
Foreword: Why a textbook? Why this textbook?
Preface: PCR-EAPCI Percutaneous Interventional Cardiovascular Medicine Textbook: a step and benchmark for a future model in education
Introduction: Bringing it all together, the Genesis of the PCR EAPCI textbook

1.1 - A history of cardiac catheterisation
1.2 - A history of percutaneous coronary intervention
1.3 - Right and left heart catheterisation
1.4 - Vascular access
1.5 - Vascular closure
1.6 - Cardiac transseptal catheterisation
1.7 - Catheterisation for peripheral diagnostic and interventional procedures
1.8 - Cardiac catheterisation in children and adults with grown-up congenital heart disease
1.9 - Endomyocardial biopsy
1.10 - Pericardiocentesis
1.11 - Percutaneous ventricular assistance
1.12 - Radiation protection
1.13 - Contrast agents and renal protection
1.14 - Sedation, pain management and resuscitation
1.15 - Biostatistics for the interventionist
2.1 - Cardiac biomarkers
2.2 - Fundamentals of coronary biomechanics
2.3 - Non-invasive imaging for coronary disease
2.4 - Non-invasive imaging for structural heart disease
2.5 - Imaging for peripheral artery disease
2.6 - Invasive diagnostic coronary angiography
2.7 - Invasive haemodynamic assessment
2.8 - Invasive physiological assessment of coronary disease
2.9 - Assessment of coronary vasoreactivity and the microcirculation
2.10 - Intracardiac echocardiography
2.11 - Intravascular ultrasound
2.12 - Optical coherence tomography
2.13 - Near-infrared spectroscopy

VOLUME II

3.1 - Guide catheters and wires
3.2 - Balloon angioplasty technology
3.3 - Coronary artery stents
3.4 - Bioresorbable scaffolds
3.5 - Drug-coated balloons
3.6 - Rotational atherectomy
3.7 - Directional atherectomy
3.8 - Laser therapy
3.9 - Distal protection and thrombectomy
3.10 - Bifurcation lesions
3.11 - Ostial lesions
3.12 - Left main coronary artery disease
3.13 - Chronic total occlusions
3.14 - Saphenous vein graft disease
3.15 - Risk stratification and risk models in revascularisation
3.16 - Interventions for stable coronary disease
3.17 - Interventions for ST-segment elevation acute myocardial infarction
3.18 - Interventions for non-ST-segment elevation acute coronary syndromes
3.19 - Interventions for patients with diabetes mellitus
3.20 - Interventions for patients with chronic renal disease
3.21 - Secondary revascularisation
3.22 - Hybrid interventions
3.23 - Cardiogenic shock
3.24 - The prevention and management of complications during percutaneous coronary intervention
3.25 - Stent thrombosis
3.26 - In-stent restenosis
3.27 - Peri-procedural and post-procedural antithrombotic pharmacotherapy
3.28 - Secondary prevention and follow-up

VOLUME III

3.29 - Percutaneous interventions in mitral and tricuspid stenosis and in failure of mitral and tricuspid bioprostheses
3.30 - Percutaneous mitral valve repair
3.31 - Balloon aortic valvuloplasty
3.32 - Transcatheter aortic valve implantation
3.33 - Percutaneous pulmonary valvuloplasty
3.34 - Percutaneous pulmonary valve implantation
3.35 - Atrial septal defect and patent foramen ovale closure
3.36 - Ventricular septal defect closure
3.37 - Patent ductus arteriosus closure
3.38 - Left atrial appendage occlusion
3.39 - Coarctation of the aorta
3.40 - Interventions for congenital and acquired pulmonary vein stenosis
3.41 - Percutaneous closure of paravalvular leaks
3.42 - Carotid artery stenting
3.43 - Subclavian, brachiocephalic and vertebral interventions
3.44 - Thoracic and abdominal aortic disease
3.45 - Interventions in the reno-visceral circulation
3.46 - Peripheral arterial occlusive disease
3.47 - Interventions for varicose veins
3.48 - Closure of arteriovenous fistulae and malformations
3.49 - Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
3.50 - Alternative techniques to alcohol septal ablation for hypertrophic obstructive cardiomyopathy
3.51 - Renal sympathetic denervation
3.52 - Techniques of myocardial stem cell delivery
3.53 - Cell-based regenerative therapy
3.54 - Pulmonary embolism and pulmonary hypertension

VOLUME IV

4.1 - The Heart team
4.2 - Patient information, ethics, and informed consent
4.3 - The cardiac catheterisation laboratory environment
4.4 - Administration and data collection
4.5 - Registry studies and post-marketing surveillance
4.6 - Clinical trial design
4.7 - Quality of life assessment
4.8 - Risk-benefit analysis
4.9 - Cost and cost-effectiveness
4.10 - Interventional cardiology training
4.11 - Consensus on definitions of clinical endpoints : percutaneous coronary and valvular intervention trials
4.12 - Consensus on definitions of clinical endpoints : carotid artery and supra-aortic trunk revascularisation trials
5.1 - Interventional pharmacology
5.2 - Interventional innovation landscape
5.3 - ARC definitions of clinical endpoints for interventional trials
5.4 - Cardiology audit and registration data standards
5.5 - Abridged ESC guidelines for interventional practice
5.6 - The global burden of cardiovascular disease